Oneok New (OKE) Stake Maintained by Brown Advisory Securities Llc; Abbott Labs (ABT) Stock Price Rose While Marshall Wace Llp Has Cut Its Stake by $18.52 Million

June 17, 2018 - By Vivian Currie

ONEOK, Inc. (NYSE:OKE) Logo

Paul Marshall decreased its stake in Abbott Labs (ABT) by 87.74% based on its latest 2018Q1 regulatory filing with the SEC. Marshall Wace Llp sold 313,864 shares as the company’s stock rose 3.04% while stock markets declined. The hedge fund run by Paul Marshall held 43,838 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $2.63 million, down from 357,702 at the end of the previous reported quarter. Marshall Wace Llp who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $110.29 billion market cap company. The stock decreased 0.08% or $0.05 during the last trading session, reaching $62.91. About 11.86 million shares traded or 106.01% up from the average. Abbott Laboratories (NYSE:ABT) has risen 41.91% since June 17, 2017 and is uptrending. It has outperformed by 29.34% the S&P500. Some Historical ABT News: 31/05/2018 – Abbott Introduces the Afinion 2 Analyzer Rapid Test System for Diabetes Management; 20/04/2018 – Mercer County: FRIENDS, NATURE CENTER TO HOST RECEPTION FOR `EXPLORING THE ABBOTT MARSHLANDS’ EXHIBIT; 18/04/2018 – Abbott Labs Sees FY Adj EPS $2.80-Adj EPS $2.90; 23/05/2018 – ABBOTT REPORTS POSITIVE OUTCOMES OF TENDYNE DEVICE STUDY; 17/04/2018 – FDA: Battery Performance Alert and Cybersecurity Firmware Updates for Certain Abbott (formerly St. Jude Medical) Implantable; 28/03/2018 – Abbott and Bigfoot previously agreed to integrate Abbott’s new continuous glucose monitor, FreeStyle Libre, with Bigfoot’s insulin delivery systems; 23/04/2018 – ABBOTT LABORATORIES – CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES; 28/03/2018 – Abbott has invested an undisclosed amount in Bigfoot Biomedical, a start-up creating diabetes care devices and systems; 18/04/2018 – Abbott Labs 1Q Adj EPS 59c; 26/04/2018 – MEDIA-Abbott India stops importing Xience Alpine stents – Economic Times

Brown Advisory Securities Llc increased its stake in Oneok Inc New (OKE) by 194.08% based on its latest 2018Q1 regulatory filing with the SEC. Brown Advisory Securities Llc bought 10,036 shares as the company’s stock rose 14.65% while stock markets declined. The institutional investor held 15,207 shares of the public utilities company at the end of 2018Q1, valued at $863,000, up from 5,171 at the end of the previous reported quarter. Brown Advisory Securities Llc who had been investing in Oneok Inc New for a number of months, seems to be bullish on the $27.86B market cap company. The stock decreased 2.25% or $1.56 during the last trading session, reaching $67.78. About 4.01 million shares traded or 71.91% up from the average. ONEOK, Inc. (NYSE:OKE) has risen 27.55% since June 17, 2017 and is uptrending. It has outperformed by 14.98% the S&P500. Some Historical OKE News: 19/04/2018 – ONEOK BOOSTS QTR DIV TO 79.5C/SHR FROM 77C, EST. 79C; 01/05/2018 – ONEOK MAINTAINS 2018 FINL GUIDANCE; 03/04/2018 – OKE: NOTIFICATION TO CUSTOMERS MISINTERPRETED; 02/05/2018 – ONEOK DOES NOT EXPECT BAKKEN FLARING RULE CHANGE TO IMPACT CO; 16/03/2018 – Oneok Inc Closes Above 50-Day Moving Average: Technicals; 03/04/2018 – Oneok: Move Was Purely Precautionary Step After EDI Was Target of Apparent Cyberattack; 06/04/2018 – Oneok Inc Presenting at Mizuho Energy Summit Apr 9; 19/04/2018 – ONEOK INC – INCREASED ONEOK’S QUARTERLY DIVIDEND 2.5 CENTS PER SHARE, OR 3 PERCENT COMPARED WITH ITS PRIOR DIVIDEND, TO 79.5 CENTS PER SHARE; 17/04/2018 – ONEOK INC OKE.N : SEAPORT GLOBAL STARTS WITH NEUTRAL, $60 TARGET PRICE; 03/04/2018 – Oneok: No Operational Interruptions on Oneok’s Pipelines

More news for Abbott Laboratories (NYSE:ABT) were recently published by: Fool.com, which released: “3 High-Yield Stocks at Rock-Bottom Prices” on June 15, 2018. Globenewswire.com‘s article titled: “Report: Developing Opportunities within Abbott Laboratories, Markel, Microsoft, Gazit-Globe, National General, and …” and published on June 14, 2018 is yet another important article.

Since January 30, 2018, it had 1 buy, and 20 insider sales for $22.32 million activity. 56,401 shares were sold by Fussell Stephen R, worth $3.36 million. $17,609 worth of Abbott Laboratories (NYSE:ABT) was sold by Watkin Jared. STARKS DANIEL J bought 40,037 shares worth $2.43M. Ford Robert B sold $2.69 million worth of stock. $53,369 worth of Abbott Laboratories (NYSE:ABT) was sold by Salvadori Daniel Gesua Sive. The insider Bracken Sharon J sold 1,053 shares worth $62,056.

Investors sentiment decreased to 0.83 in Q1 2018. Its down 0.08, from 0.91 in 2017Q4. It turned negative, as 44 investors sold ABT shares while 606 reduced holdings. 126 funds opened positions while 411 raised stakes. 1.22 billion shares or 0.54% more from 1.22 billion shares in 2017Q4 were reported. Banque Pictet Cie Sa holds 0.42% or 332,451 shares. Seabridge Invest Advsrs Limited Liability holds 0.04% or 2,875 shares in its portfolio. Wall Street Access Asset Ltd owns 4,468 shares. Swarthmore Inc invested 2.04% in Abbott Laboratories (NYSE:ABT). Mountain Pacific Inv Advisers Inc Id invested in 0.21% or 33,701 shares. The Missouri-based Parkside Fin Fincl Bank And Tru has invested 0.27% in Abbott Laboratories (NYSE:ABT). Greylin Mangement Incorporated has invested 0.6% of its portfolio in Abbott Laboratories (NYSE:ABT). 1832 Asset Mgmt Lp holds 0.03% of its portfolio in Abbott Laboratories (NYSE:ABT) for 126,620 shares. Ftb has invested 0.12% of its portfolio in Abbott Laboratories (NYSE:ABT). Clarkston Prtn Limited Liability Co stated it has 0.01% of its portfolio in Abbott Laboratories (NYSE:ABT). Trustmark State Bank Tru Department owns 19,141 shares. Cove Street Cap Limited Liability Company invested in 1,500 shares. Silvercrest Asset Mngmt Grp Limited Liability Company has invested 1.4% in Abbott Laboratories (NYSE:ABT). Ohio-based Keybank Association Oh has invested 0.51% in Abbott Laboratories (NYSE:ABT). Verition Fund Mgmt Ltd Company owns 41,631 shares for 0.19% of their portfolio.

Marshall Wace Llp, which manages about $2.41B US Long portfolio, upped its stake in Gen Cable Corp (NYSE:BGC) by 402,709 shares to 453,355 shares, valued at $13.42M in 2018Q1, according to the filing. It also increased its holding in Micron Tech (NASDAQ:MU) by 112,100 shares in the quarter, for a total of 246,729 shares, and has risen its stake in Ameriprise Finan (NYSE:AMP).

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 107 analyst reports since July 24, 2015 according to SRatingsIntel. JP Morgan maintained the shares of ABT in report on Thursday, January 25 with “Overweight” rating. Gabelli maintained the stock with “Buy” rating in Friday, July 21 report. The rating was maintained by BMO Capital Markets with “Hold” on Thursday, July 20. The firm has “Outperform” rating given on Tuesday, December 12 by BMO Capital Markets. The company was maintained on Wednesday, April 19 by Stifel Nicolaus. The firm has “Outperform” rating given on Wednesday, March 1 by RBC Capital Markets. As per Thursday, January 25, the company rating was upgraded by William Blair. The company was maintained on Thursday, October 19 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Friday, September 1 with “Buy”. The company was maintained on Thursday, July 20 by Stifel Nicolaus.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on July, 19. They expect $0.71 EPS, up 14.52% or $0.09 from last year’s $0.62 per share. ABT’s profit will be $1.24 billion for 22.15 P/E if the $0.71 EPS becomes a reality. After $0.59 actual EPS reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 20.34% EPS growth.

Investors sentiment increased to 1.35 in 2018 Q1. Its up 0.17, from 1.18 in 2017Q4. It increased, as 52 investors sold OKE shares while 174 reduced holdings. 82 funds opened positions while 223 raised stakes. 297.11 million shares or 9.86% more from 270.44 million shares in 2017Q4 were reported. 46,788 are held by Symphony Asset Mgmt Ltd Llc. Alps Advisors has invested 0.44% in ONEOK, Inc. (NYSE:OKE). Leavell Inv Mngmt stated it has 13,501 shares. Everett Harris Ca invested in 195,816 shares. Maryland-based Edgemoor Investment Advsrs has invested 0.09% in ONEOK, Inc. (NYSE:OKE). Sumitomo Mitsui Asset holds 26,661 shares or 0.02% of its portfolio. Advisor Prns Llc owns 10,688 shares. Cap Rech Global Investors, a California-based fund reported 7.25 million shares. Navellier & Associates owns 39,605 shares. Blackhill, New Jersey-based fund reported 40,777 shares. Rodgers Brothers stated it has 0.29% of its portfolio in ONEOK, Inc. (NYSE:OKE). Interocean Cap Ltd Liability Co reported 0.05% of its portfolio in ONEOK, Inc. (NYSE:OKE). Atlantic Grp Inc Incorporated Lc invested 0.33% of its portfolio in ONEOK, Inc. (NYSE:OKE). Smithfield Tru holds 3,641 shares or 0.03% of its portfolio. Reilly Financial Advisors stated it has 205 shares or 0% of all its holdings.

Abbott Laboratories (NYSE:ABT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts